The School of Biosciences and Medicine is committed to the Athena SWAN principles, recognising that academia will achieve maximum potential by embracing diversity and combatting inequality. We are proud to hold a Bronze Athena SWAN award and are working towards our Silver application.
Our biosciences graduates have secured roles at multinational companies and prestigious institutions such as:
Our mission is to improve human and animal health through top-ten teaching and world-leading discovery and translational research in biosciences and medicine.
Dr Simon Archer, University of Surrey comments on a new study linking increased screen time, particularly at bedtime to a poorer quality of sleep.
Our food science programmes are ranked number one in the UK by both The Times and Sunday Times Good University Guide 2017 and The Complete University Guide 2018.
As a Sport and Exercise Sciences student you'll have access to the Surrey Human Performance Institute, which provides a range of physiological assessments to help people learn more about their health status and optimise their fitness and performance.
The University of Surrey is delighted to announce that Dr Rachel Simmonds, Lecturer in Immunopathogenesis from the School of Biosciences and Medicine, has received a highly prestigious Investigator Award in Science from the Wellcome Trust for her research on the neglected tropical disease, Buruli ulcer. These highly competitive awards provide substantial funding for innovative scientists with an excellent track record who prove they can drive advances in their field.
A study, published in the American Journal of Clinical Nutrition, has shown high levels of vitamin D inadequacy in UK adolescents, and – for the first time – identified the intake needed by adolescents in order to maintain adequate serum vitamin D levels during the winter time.
The first successful clinical trial of an adjuvant treatment for patients who have had kidney cancer has been carried out by an international team of oncology experts. Released during the Presidential Address of the ESMO 2016 Congress in Copenhagen on 10 October, the results of the trial are likely to change clinical practice worldwide.
